four hundred forty previously untreated patients with active multiple myeloma were entered into a randomized trial ( southwest oncology group [ swog ] study 7927/28 ) comparing vincristine , melphalan , cytoxan ( mead johnson & company , evansville , ind ) , and prednisone ( vmcp ) alternating with vincristine , bcnu , adriamycin ( adria laboratories , columbus , ohio ) and prednisone ( vbap ) with or without levamisole with vincristine , cytoxan , and prednisone ( vcp ) with or without levamisole for induction therapy .
C0026764
multiple myeloma
C0025241
melphalan